AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish by Goodale, Britton C. et al.
AHR2 Mutant Reveals Functional Diversity of Aryl
Hydrocarbon Receptors in Zebrafish
Britton C. Goodale
1, Jane K. La Du
1, William H. Bisson
2, Derek B. Janszen
3, Katrina M. Waters
3, Robert L.
Tanguay
1*
1Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Oregon State University, Corvallis, Oregon, United States of America,
2Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland, 3Computational Biology and Bioinformatics Group,
Pacific Northwest National Laboratory, Richland, Washington, United States of America
Abstract
The aryl hydrocarbon receptor (AHR) is well known for mediating the toxic effects of TCDD and has been a subject of
intense research for over 30 years. Current investigations continue to uncover its endogenous and regulatory roles in a wide
variety of cellular and molecular signaling processes. A zebrafish line with a mutation in ahr2 (ahr2
hu3335), encoding the AHR
paralogue responsible for mediating TCDD toxicity in zebrafish, was developed via Targeting Induced Local Lesions IN
Genomes (TILLING) and predicted to express a non-functional AHR2 protein. We characterized AHR activity in the mutant
line using TCDD and leflunomide as toxicological probes to investigate function, ligand binding and CYP1A induction
patterns of paralogues AHR2, AHR1A and AHR1B. By evaluating TCDD-induced developmental toxicity, mRNA expression
changes and CYP1A protein in the AHR2 mutant line, we determined that ahr2
hu3335 zebrafish are functionally null. In silico
modeling predicted differential binding of TCDD and leflunomide to the AHR paralogues. AHR1A is considered a non-
functional pseudogene as it does not bind TCCD or mediate in vivo TCDD toxicity. Homology modeling, however, predicted
a ligand binding conformation of AHR1A with leflunomide. AHR1A-dependent CYP1A immunohistochemical expression in
the liver provided in vivo confirmation of the in silico docking studies. The ahr2
hu3335 functional knockout line expands the
experimental power of zebrafish to unravel the role of the AHR during development, as well as highlights potential activity
of the other AHR paralogues in ligand-specific toxicological responses.
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Introduction
The aryl hydrocarbon receptor (AHR), while best known for its
role as an environmental sensor and mediator of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) toxicity, has captured atten-
tion in recent years with a growing body of research elucidating its
endogenous functions. As a member of the bHLH-Per-Arnt-
Sim(PAS) family of proteins, the AHR is a transcriptional
regulator containing two evolutionarily-conserved domains: a
basic helix-loop-helix (bHLH) domain, which enables binding to
aromatic hydrocarbon-responsive elements (AHREs), and a PAS
domain, consisting of two 51- amino acid imperfect repeats (PAS-
A and PAS-B), responsible for dimerization, ligand binding and
interactions with other proteins [1,2]. Originally discovered for its
role in modulating TCDD sensitivity in mice, the AHR binds a
wide variety of ligand structures, including polycyclic and
halogenated aromatic hydrocarbons (PAH and HAHs). Ligand
binding induces disassociation from a cytoplasmic protein complex
and translocation to the nucleus where the AHR heterodimerizes
with the aryl hydrocarbon nuclear translocator (ARNT) [3,4,5].
The AHR-ARNT heterodimer, along with other transcriptional
enhancers, binds to AHREs and activates transcription of CYP1A,
as well as NQO1, ALDH3A1, UGT1A6 and many other genes
involved in metabolism, oxidative stress response and cell signaling
[6,7]. The role of the AHR in mediating toxicity of environmental
contaminant exposure has been extensively studied (reviewed in
[8,9,10]), and mechanism of action in immune, reproductive,
developmental and other toxicological responses remain active
areas of investigation. The diversity of physiological systems
impacted by AHR activation and its crosstalk with other
regulatory pathways support the notion that endogenous functions
for the receptor likely preceded its role as an environmental sensor
[11].
TCDD binding activity of the AHR is conserved among
vertebrates. Substitutions in critical residues produce variation in
ligand affinity, which underlies differences in TCDD sensitivity
between species, inbred mouse strains, and wild fish populations
[4,12,13,14]. Structural comparisons of receptors provide infor-
mation necessary for risk assessment extrapolation between
species, as well as insight into receptor evolution [15]. In addition,
in silico modeling of the AHR has emerged as a powerful screening
tool for identifying novel AHR ligands [16,17].
Developing fish embryos are extremely sensitive to AHR-
mediated planar hydrocarbon toxicity and hold a number of
experimental advantages including development external to the
mother, ease of observation, and genetic tractability. As such,
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signaling processes in the context of xenobiotic exposures [18,19].
In teleosts, genome-wide duplication events have resulted in co-
orthologs for many mammalian genes. While some gene duplicates
have become non-functional, others have been evolutionarily
conserved via the partitioning of functions between paralogues
[20]. Three AHR isoforms have been identified in zebrafish:
AHR1A, AHR1B, and AHR2 [12,21,22,23]. Numerous studies
with known AHR ligands, however, have identified AHR2 as the
primary mediator of early life stage toxicological effects in
zebrafish [24,25,26]. Antisense oligonucleotide (morpholino)
knockdown of AHR2 affords almost complete resistance to
TCDD-induced developmental toxicity, and prevents the inhib-
itory effects of AHR ligands on epimorphic regeneration [25,27].
Toxicity of many other HAHs and PAHs is also primarily
dependent on AHR2. While AHR1B does bind TCDD, it is less
sensitive to activation by TCDD than AHR2 [23,24,28]. In
contrast, AHR1A does not bind TCDD and is deficient in
transactivation activity [21,23]. Beyond functioning as xenobiotic
sensors, the zebrafish AHR paralogues are proposed to serve
endogenous functions that have yet to be elucidated.
Recent studies have highlighted endogenous roles for the AHR
in a complex array of immune system, cell cycle regulatory,
reproductive and developmental processes [10,29,30,31,32]. AHR
knockout mouse strains developed by three different groups
illustrate the importance of the AHR in normal liver development
and immune function, and continue to expand understanding of
the receptor’s role in both toxicological responses and normal
physiology [33,34,35]. A functional zebrafish AHR2 knockout line
will allow for investigation of the biological functions of the
receptor throughout the zebrafish lifespan, and will eliminate the
concern of incomplete knockdown that can occur with morpho-
linos. Complete loss of AHR2 activity in a zebrafish line will also
enable functional analysis of the other two receptors, which has to
date been experimentally difficult. As the primary mediator of
TCDD toxicity, we proposed AHR2 as a target of great value to
the zebrafish community for Targeting Induced Local Lesions IN
Genomes (TILLING). Here we describe characterization of AHR
function in the first TILLING-indentified AHR2 mutant zebra-
fish. We report loss of AHR2 function in a mutant AHR2 line, and
present evidence of ligand- and tissue-specific activation and
function of AHR1A and AHR1B.
Results
Generation of a functionally null AHR2 zebrafish line
The ahr2
hu3335 line was established, upon request, by the
Hubrecht institute from a TILLING-identified founder with a
TTG to TAG point mutation in residue Leu534, resulting in a
premature stop codon in the transactivation domain of AHR2
(Figure 1). While the bHLH and PAS domains are predicted to
remain intact in the truncated protein, the transactivation domain
of zebrafish AHR2 is required for transcriptional activation [21].
In addition, the premature stop codon location is .55 nucleotides
upstream of an exon-exon boundary, likely rendering the mutant
AHR2 mRNA a target of nonsense-mediated mRNA decay,
which will be further discussed below [36].
ahr2
hu3335 zebrafish survived to adulthood with no consistently
observed abnormalities during development. Jaw, gill and fin
malformations were observed in adult fish, but did not appear to
cause significant morbidity or mortality. The fins of ahr2
hu3335
adult zebrafish are damaged compared to their ahr2
+ clutch mates,
a characteristic which persisted in the offspring of wild-type 5D-
outcrossed ahr2
hu3335/+ zebrafish (Figure 2A,B). Visible jaw
malformations in ahr2
hu3335 adults prompted us to investigate
bone structure using non-destructive microCt scanning. MicroCt
imaging revealed structural differences in the neurocrania of an
ahr2
hu3335 and an aged-matched wild-type strain 5D adult
zebrafish, including a striking extension of the ethmoid and
mandibular regions (Figure 2C,D) [37]. Further, the dentary,
maxilla and premaxilla of the ahr2
hu3335 zebrafish had notably
different structure, creating an extended mandible. Other bones,
such as the orbitals and supraorbitals, appeared smaller in the
ahr2
hu3335 zebrafish, which may be an artifact of scanning reduced
bone thickness compared to the wild type [37].
In comparison to their ahr2
+ and ahr2
+/hu3335 siblings, spawning
activity of ahr2
hu3335 homozygous crosses was less robust and egg
fertilization rates were low (50–75%). As is discussed further in
regard to developmental toxicity assays, pericardial edema and jaw
malformations occurred with higher incidence in some of the
ahr2
hu3335 clutches. Sporadic spawning activity of ahr2
hu3335
homozygous crosses and successful in vitro fertilization demon-
strated that the ahr2
hu3335 mutation does not prevent reproductive
function in this line. Irregular spawning, however, suggests deficits
in reproductive physiology or behavior.
ahr2
hu3335 embryos are resistant to TCDD-induced
developmental toxicity
To assess AHR2 function in the ahr2
hu3335 strain, we compared
developmental toxicity of TCDD in the ahr2
hu3335 mutants to
ahr2
+ embryos. Exposure to 0.1, 1 or 10 nM TCDD resulted in a
concentration-dependent increase in axis malformations and
pericardial edema observed at 120 hpf in the ahr2
+ embryos
(Figure 3A,C). Of the fifteen endpoints evaluated, TCDD
concentration was significantly correlated with increases in yolk
sac and pericardial edemas, and axis, eye, snout, jaw and trunk
malformations (Table 1). Mortality, touch response, fin, pigment,
brain, circulatory, somite and otic malformations were not
significant responses in either fish line. ahr2
hu3335 embryos were
resistant to TCDD-dependent malformations, and the responses of
ahr2
+ and ahr2
hu3335 embryos to TCDD exposure were signifi-
cantly different from each other (Figure 3A,B,D, Table 1).
Background pericardial edema and jaw malformations were
observed in ahr2
hu3335 embryos but were not TCDD-dependent.
mRNA expression indicates the ahr2
hu3335 mutation
abrogates AHR2 function
We evaluated mRNA expression to further assess AHR2
function, and observed a 16-fold difference in AHR2 transcript
abundance between ahr2
+ and ahr2
hu3335 embryos (Figure 4A).
This supports the hypothesis that AHR2 mRNA is degraded in the
ahr2
hu3335 line. We next examined AHR2-dependent gene
expression to determine whether the point mutation perturbs
expression of downstream transcriptional targets. Expression of
CYP1A, CYP1B1, CYP1C1, CYP1C2, AHR1A and AHR1B
transcripts were not significantly different between ahr2
hu3335 and
ahr2
+ embryos (Figure 4A).
To further confirm the lack of AHR2 functionality, we
investigated mRNA expression changes in response to TCDD,
which induces AHR2-dependent expression of a number of
mRNAs at 48 hpf [38]. Developmental TCDD exposure induced
robust expression of CYP1A, CYP1C1 and CYP1C2 mRNA at 48
hpf in ahr2
+ embryos relative to vehicle-treated controls
(Figure 4B). As expected in the absence of a functional AHR2,
mRNA expression was not significantly elevated in ahr2
hu3335
embryos exposed to TCDD (Figure 4C).
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We recently reported a homology model that has been used to
predict binding affinity of potential ligands to the human, mouse
and zebrafish AHRs [39]. In order to investigate differential
function of the zebrafish AHR paralogues, we tested TCDD and a
known AHR ligand with a non-classical structure, leflunomide, in
a series of molecular docking studies. Sequence alignment of the
mouse and zebrafish AHR-PASB domains produced identities of
65.1% (zfAHR1A), 78.5% (zfAHR1B) and 70.5% (zfAHR2). High
similarity between the three isoforms at the primary and predicted
tertiary structural levels was also noted, with 74.3% (AHR2/1B)
and 69.9% (AHR1B/1A) identity. TCDD and leflunomide were
docked into zebrafish AHR1A-, AHR1B-, and AHR2-LBD
homology models. TCDD docked in AHR2 and AHR1B with
predicted binding energies of 23.97 kcal/mol and 24.86 kcal/
mol, respectively, but was unable to dock in AHR1A (Table 2,
Figure 5A,B). Leflunomide was also able dock in AHR2 and
AHR1B, with predicted binding energies of 22.13 kcal/mol and
21.97 kcal/mol, respectively (Table 2, Figure 5C,D). Interesting-
ly, in contrast to TCDD, leflunomide docked into AHR1A, but in
a unique orientation [17] (Figure 5E).
AHR1A possesses specific residues that play potential roles in
TCDD insensitivity [23]. Key residues characterized in the mouse
AHR-LBD influencing TCDD binding are conserved in zebrafish
AHR2 and AHR1B, which are both TCDD sensitive [17,40,41].
In AHR1A, residues His296, Ala386 and Gln388 have been
substituted with Tyr296, Thr386 and His388 [23]. The side chains
of these residues cause both decreased volume and altered polarity
of the AHR1A binding pocket, in comparison to AHR2, AHR1B,
as well as mouse and human AHRs [17]. TCDD docking is
consequently not possible in AHR1A, which has been confirmed
both in vitro and in vivo [21,23]. Homology modeling predicted that
leflunomide, however, is able to dock in AHR1A with a unique
orientation not found in human, mouse, or zebrafish AHR1B and
AHR2 isoforms [39]. As shown previously, leflunomide docks in
AHR2 and AHR1B with a hydrogen bond (HB) interaction
between the nitrogen atom of the isoxazole ring of the ligand and
the OH of the side chain of Thr294 ([39], Figure 5C,D). Here we
employed the homology model to examine AHR1A interaction
with leflunomide for the first time, and discovered that the
leflunomide docking position is flipped and a double HB
interaction between the nitrogen and oxygen of the isoxazole ring
of the ligand and the side chain of Thr354 is formed (Figure 5E). A
binding energy of 22.19 kcal/mol was predicted which is in the
range calculated for the other two isoforms (Table 2). Based on
these data, we predicted that leflunomide would be a functional
AHR1A ligand.
CYP1A protein induction patterns are ligand- and AHR
isoform-dependent
We used immunohistochemical analysis of CYP1A protein
expression as a biomarker of AHR activation to investigate in vivo
AHR ligand binding patterns in TCDD and leflunomide-exposed
larvae. Exposure to 1 nM TCDD from 6–24 hpf induces AHR2-
dependent CYP1A expression in a number of tissues, including the
heart, liver and enteric tract, with the predominant expression in
the vascular endothelium of larvae (Figure 6A) [42]. We focused
our evaluation of AHR function on the most robust CYP1A
induction patterns, which were observed in vasculature and liver
[42,43]. As predicted by the qRT-PCR results, CYP1A protein
expression in TCDD-exposed ahr2
hu3335 larvae was limited to faint
vascular expression, just above background, in all embryos
examined (Figure 6B). Exposure to 10 nM TCDD, which induced
severe malformations and robust CYP1A expression in wild-type
embryos, did not notably increase CYP1A expression in ahr2
hu3335
larvae (data not shown).
To confirm the predicted binding of leflunomide to all three
zebrafish AHRs in vivo, we examined CYP1A induction in
ahr2
hu3335 larvae exposed to 10 mM leflunomide from 48–72 hpf.
In comparison to wild type larvae, vascular CYP1A expression was
drastically reduced in leflunomide-exposed ahr2
hu3335 larvae
(Figure 6C, D). In contrast to TCDD exposure, however,
AHR2-independent CYP1A expression was observed in the
developing livers of leflunomide-exposed ahr2
hu3335 larvae
(Figure 6D). This expression pattern persisted in larvae exposed
until 120 hpf, with vascular expression remaining low and liver
expression increasing, likely due to growth that occurs from 72–
120 hpf (data not shown).
Based on molecular docking studies, we hypothesized that
leflunomide induced CYP1A in ahr2
hu3335 larvae via activation of
the other AHR homologs, and utilized splice-blocking morpholi-
nos to transiently knock down AHR1A and AHR1B separately
Figure 1. Schematic diagram of predicted AHR2 protein in ahr2
hu3335 zebrafish. The ahr2
hu3335 zebrafish line has a T to A point mutation in
residue 534, resulting in a premature stop codon in the transactivation domain of the protein. The predicted truncated protein contains the ligand
binding, DNA binding and ARNT binding domains, but lacks the transactivation domain previously shown to be essential for a functional AHR2
protein [21,58]. NLS: nuclear localization signal, NES1: nuclear export signal 1, NES2: nuclear export signal 2.
doi:10.1371/journal.pone.0029346.g001
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of CYP1A expression at 72 hpf to capture the window of
morpholino efficacy, which was confirmed with PCR using
primers flanking the target sites (Figure S1). As the liver is small
at 72 hpf, we employed double-staining with a hepatocyte nuclear
factor 4a (HNF4a) antibody to confirm the presence of
hepatocytes [44] (data not shown). CYP1A expression in AHR1B
morpholino-injected ahr2
hu3335 larvae persisted in the liver
(Figure 6E), but was notably absent in the vasculature. In contrast,
injection of the AHR1A morpholino in ahr2
hu3335 embryos
blocked leflunomide-induced expression of CYP1A in the liver,
while faint vascular expression remained. When co-injected, the
AHR1A and AHR1B morpholinos blocked all CYP1A expression
in leflunomide-exposed ahr2
hu3335 larvae (Figure 6F). When
expression of all 3 AHR isoforms was eliminated, CYP1A
expression in leflunomide-exposed embryos was indistinguishable
from vehicle-exposed controls (Figure 6G).
Discussion
ahr2
hu3335 zebrafish, homozygous for a point mutation in ahr2,
survive to adulthood and are functional AHR2 knockouts by all
Figure 2. Fin and skeletal abnormalities observed in adult ahr2
hu3335 zebrafish. A–B) Brightfield and (C–D) microCt imaging of adult ahr2
+
and ahr2
hu3335zebrafish. Notable differences were observed in the dentate (d), premaxilla (pm), maxilla (mx), supraorbital (so), infraorbital 3(inf) and
operculum (op).
doi:10.1371/journal.pone.0029346.g002
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predicted to result in a non-functional protein due to its truncated
transactivation domain. Though we cannot exclude the possibility
that some biological activity of a potential cryptic protein remains,
we saw no evidence to support its presence. Analysis of ahr2
hu3335
mRNA levels suggests that the mutant AHR2 transcript is at least
partially degraded and the truncated protein may be present only
at very low levels, if at all.
The ahr2
hu3335 adult zebrafish exhibit notable fin and skeletal
differences compared to wild type. We also observed a higher
background of developmental abnormalities in ahr2
hu3335 larvae.
These phenotypes may not necessarily be due to the mutation;
reduced spawning and small clutch sizes of ahr2
hu3335 zebrafish
limited the choice of embryos for experiments, whereas large wild
type clutches allow for precise selection of high-quality embryos.
Studies in both AHR-deficient and AHR ligand-treated mice
provide strong evidence of an endogenous role of the receptor in
female reproductive physiology. Deficiencies in maintaining
pregnancy and surviving lactation have been reported in AHR
knockout mice [45], and disruption of AHR function alters
Figure 3. ahr2
hu3335 embryos are resistant to TCDD-induced developmental abnormalities. A) Percent of embryos with axis
malformations and B) percent incidence pericardial edema at 120 hpf in embryos treated with 0, 0.1, 1 or 10 nM TCDD from 6–24 hpf. Vehicle control
groups (c, 0.1% DMSO) are displayed at 10
24 for graphing purposes. Data represent three independent experiments with 20 embryos per treatment
group. C) Representative image of 120 hpf ahr2
+ and (D) ahr2
hu3335 embryos developmentally exposed to 10 nM TCDD.
doi:10.1371/journal.pone.0029346.g003
Table 1. Concentration responses for developmental effects observed in TCDD-exposed ahr2
+ and ahr2
hu3335 embryos.
Effect
p-value of ahr2
+ TCDD
concentration-response
p-value of ahr2
hu3335 TCDD
concentration-response
p-value of ahr2
hu3335 and
ahr2
+ differential response to
TCDD
yolk sac edema ,0.0001 0.7181 0.0004
Axis ,0.0001 0.2754 0.0006
Eye ,0.0001 1.0000 0.0005
Snout ,0.0001 0.6706 0.0004
Jaw ,0.0001 0.8632 0.0011
pericardial edema ,0.0001 0.0848 0.0002
doi:10.1371/journal.pone.0029346.t001
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ovulation and possibly reproductive senescence [29]. In keeping
with AHR knockout mouse models, ahr2
hu3335 zebrafish are
capable of producing viable embryos, but exhibit decreased
reproductive success. It is important to note, however, that other
ENU-induced mutations throughout the genome of this fish line
could be responsible for observed phenotypic abnormalities.
Zebrafish TILLING mutants require multiple outcrosses to reduce
undesired mutations to background levels. Because outcrosses of
the ahr2
hu3335 line were in progress at the time of this study, it is
premature to attribute all phenotypic abnormalities observed in
ahr2
hu3335 homozygotes to the mutation in ahr2. Decreased
reproductive capacity of homozygous mutants, as well as fin and
jaw abnormalities may represent interesting models of endogenous
AHR function and certainly warrant further investigation if they
persist in the mutant line following further outcrosses.
In the present study, we used TCDD as a tool to investigate
AHR2 function in the ahr2
hu3335 line. We found that ahr2
hu3335
embryos were resistant to TCDD-induced developmental toxicity
at concentrations that cause severe malformations in ahr2
+
embryos. ahr2
hu3335 embryos treated with 10 nM TCDD showed
few signs of morbidity at 120 hpf. Transient AHR2 knockdown
delays, but does not prevent, TCDD-induced mortality [25].
Therefore it would be interesting to examine longer-term effects of
TCDD exposure in future experiments with the ahr2
hu3335 line.
The most well-known biomarker of AHR activation is the
induction of CYP1A expression. Among the suite of cytochrome
P450 metabolizing enzymes in zebrafish, CYP1A, CYP1B1,
CYP1C1 and CYP1C2 are elevated in response to AHR agonist
exposure [38]. In agreement with our developmental toxicity data,
no elevation in CYP1A, CYP1C1 or CYP1C2 expression was
observed in TCDD-exposed ahr2
hu3335 embryos. Taken together,
these data support the concept that AHR2 is not functional in this
line. The notable, but statistically insignificant, increase in CYP1A
expression following TCDD treatment in ahr2
hu3335 embryos is
likely due to TCDD activation of AHR1B, as further discussed
below.
While the dependence of CYP1A activation by TCDD on
AHR2 is well-established, studies with PAHs in zebrafish embryos
have revealed diverse CYP1A expression patterns dependent on
other AHR isoforms [46,47]. This study represents the first time
that an in silico-based modeling approach was utilized to investigate
ligand binding by all three receptors. Molecular docking with
TCDD predicted that both AHR1B and AHR2, but not AHR1A,
would bind TCDD due to substitutions in the binding pocket. In
contrast to TCDD, in silico modeling with leflunomide predicts
Figure 4. ahr2
hu3335 embryos express reduced endogenous AHR2 mRNA and are resistant to TCDD-induced CYP induction. A)
Comparative analysis of AHR1A, AHR1B, CYP1A, CYP1B1, CYP1C1 and CYP1C2 mRNA expression in wild-type 5D and ahr2
hu3335 mutant embryos at
48hpf . DDCt values were calculated by comparing sample DCt values (normalized to b-actin) to the mean ahr2
+ DCt for each gene. Data were
analyzed by paired student’s t-test, * p,.05. B) Developmental exposure (6–24 hpf) to 1 nM TCDD induced significant CYP1A, CYP1C1 and CYP1C2
expression at 48 hpf in ahr2
+ embryos. Data is shown normalized to vehicle-treated controls and was analyzed with paired student’s t-test, *p,.05, **
p,.01. C) Developmental exposure to 1 nM TCDD did not induce significant mRNA expression changes in ahr2
hu3335 embryos. While CYP1A was
elevated, the difference was not significant.
doi:10.1371/journal.pone.0029346.g004
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Interestingly, leflunomide docked into AHR1A with a different predicted
conformation than in the other two receptors, but with equivalent affinity.
This finding is particularly intriguing, as AHR1A is incapable of binding
classical AHR ligands [23], is deficient in transactivation activity [21], and
therefore was once considered non-functional.
We confirmed the AHR modeling results in vivo using CYP1A
protein expression as a biomarker of AHR activation. In keeping
with our mRNA expression and in silico modeling studies, TCDD-
exposed ahr2
hu3335 larvae were largely devoid of CYP1A protein
expression observed in TCDD-exposed ahr2
+ larvae. Leflunomide
also induces strong vascular CYP1A protein expression in ahr2
+
larvae, but unlike with TCDD, the ahr2
hu3335 embryos exhibited
striking leflunomide-induced CYP1A expression in the liver. This
finding is in agreement with the modeling results. To tease apart
AHR isoform-dependence of the residual CYP1A expression, we
transiently knocked down the receptors individually and in
combination in ahr2
hu3335 larvae. We found AHR1B-dependent
vascular induction and AHR1A-dependent liver induction of
CYP1A expression. Knockdown of AHR1A and AHR1B in
combination prevented all CYP1A induction. Taken together,
these data suggest that, contrary to previous observations with
TCDD, all three AHR isoforms are involved in leflunomide-
induced CYP1A expression in zebrafish larvae.
These data demonstrate that there are concrete differences in
ligand binding activity of the zebrafish AHRs, and that AHR1A is
not a pseudogene as previously proposed, but rather has affinity
for different ligand structures. While residual CYP1A expression
has been observed in TCDD-treated AHR2-morphants, it was
faint and vascular in nature, attributable to incomplete knockdown
[25]. Our immunohistochemical results with the ahr2
hu3335 line
suggest that mild vascular expression of CYP1A is induced via
AHR1B, and can be effectively knocked down to background with
morpholino injection. AHR1A-dependent CYP1A expression is
seemingly incongruous with previous investigation of AHR1A
function in vitro, but the lack of a known AHR1A ligand limited
previous efforts. The AHR1A-dependent CYP1A expression
pattern we observed here is consistent with the reported AHR1A
mRNA expression in the liver [21].
Putative AHR1A ligands could be identified with further in silico
modeling; work by Incardona and colleagues also offers clues with
several PAHs that induce CYP1A expression independently of
AHR2 [46,47,48]. Pyrene induced liver expression of CYP1A in
an AHR1A-dependent manner [47], and more recently retene-
induced CYP1A expression was shown to be incompletely
dependent on AHR2 [49]. Here, we offer further evidence that
AHR1A is a functional receptor in vivo, though the transactivation
requirements for this receptor remain to be elucidated. In vitro data
with AHR chimera proteins suggest that transactivation require-
ments of AHR1A differ from those of AHR2 [21].
The presence of three apparently functional aryl hydrocarbon
receptors in zebrafish raises several interesting questions: How do
these receptors differ? What functions have led to their
evolutionary conservation? And to what extent do the AHR1
receptors need to be considered in toxicological studies in
zebrafish? While the presence of multiple AHRs certainly
complicates study of receptor function in fish, subfunction
partitioning among isoforms presents a unique opportunity to
unravel the many physiological functions of the AHR that are
conserved among vertebrates [20]. As summarized in Table 3, the
studies presented here add to a body of research demonstrating
significant differences in receptor expression, ligand binding, and
mRNA induction activity. With respect to transcript localization,
AHR2 is widely distributed through most organs investigated in
adult zebrafish, while AHR1A is mainly expressed in the liver, and
to a lesser extent in the heart, kidney and swim bladder [21].
AHR1B expression has yet to be fully characterized, but our
CYP1A IHC results suggest that the isoform is widely distributed,
but is expressed at much lower levels than AHR2. The subfunction
partitioning of these receptors is not strictly locational. Overlap-
ping expression of AHR2 and AHR1A has been previously
described, and we also noted overlap in AHR2- and AHR1-
dependent CYP1A expression patterns [23,42]. A cell or tissue-
level analysis may reveal more subtle localization differences, as
has been implied in differential PAH-induced CYP1A patterns in
endocardial and myocardial tissue [47,48]. Little is yet known
about the endogenous function of these receptors and their
downstream transcriptional targets. If expression of AHR1A and
AHR1B is limited, it may be difficult to detect significant changes
in their transcriptional targets in whole embryo homogenate. As
we have shown here, however, the ahr2
hu3335 line will ease the
study of the other two receptors by removing the overpowering
transcriptional changes induced through AHR2. The three
receptors together present an intriguing opportunity to unravel
multiple regulatory functions that may be conserved in the
mammalian AHR.
This is the first report of CYP1A induction dependent on all
three of the zebrafish AHRs. Toxicity mediated through the
AHR1 receptors, however, has not, as of yet, been documented.
Pyrene-induced liver toxicity and pericardial edema were reduced
with AHR1A knockdown, but AHR2 knockdown prevented the
majority of the chemical’s developmental effects [46,47]. In the
case of TCDD and other similarly-structured HAHs, the small
binding pocket of AHR1A prevents it from having a role in ligand-
induced toxicological effects. AHR1A and AHR1B receptors may
hold little importance in toxicological studies with these com-
pounds. Indeed the studies presented here support the large body
of previous research indicating that TCDD-induced early life stage
toxicity is mediated through AHR2. Though some CYP1A and
other downstream target induction may occur via AHR1B, any
developmental abnormalities caused by this pathway are more
subtle than those investigated to date. The possibility remains,
however, that AHR1B may play a role in later life stage impacts of
TCDD. These data warrant further investigation of the AHR
isoforms with structurally diverse, less-well studied compounds.
Ultimately, further bioinformatic and modeling efforts with
zebrafish and mammalian AHRs could help determine the best
model for human AHR activity, taking into account both ligand
binding and receptor expression characteristics.
This was the first time that all three AHR isoforms were
knocked down in developing zebrafish. Our findings suggest that,
consistent with mammalian literature, AHR function is not
required to complete development [33,50]. Without full histolog-
ical evaluations of the AHR1Amo/AHR1Bmo/ahr2
hu3335 larvae
at 120hpf, we cannot exclude non-lethal malformations, particu-
larly hepatic abnormalities, which have been reported in AHR
Table 2. Predicted binding energy values for zebrafish AHR2,
AHR1B and AHR1A (kcal/mol).
AHR2 AHR1B AHR1A
TCDD 23.97 24.86 ND
Leflunomide 22.13 21.97 22.19
ND – unable to dock.
doi:10.1371/journal.pone.0029346.t002
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question of whether the AHR paralogues are required for hepatic
development in zebrafish with the tools employed here, as the liver
undergoes significant development after 72hpf, when morpholino
efficacy is in decline. We therefore present the ahr2
hu3335 line as a
valuable resource available to the zebrafish research community,
and suggest that development of both AHR1A and AHR1B
(already requested by the research community) mutant lines would
Figure 5. Molecular docking of TCDD and Leflunomide in zebrafish AHR isoforms. A) TCDD docking orientation in zebrafish AHR2- and B)
AHR1B-LBD homology model binding pocket (ICM v3.5-1n, Molsoft). C) Leflunomide docking orientation into AHR2-, D) AHR1B- and E) AHR1A
homology model binding pockets. The residues are displayed as sticks and colored by atom type with the carbon atoms in green. The protein
backbone is displayed as ribbon and colored by secondary structure. The ligand is displayed as sticks and colored by atom type with carbon atoms in
orange (A, C), magenta (B, D) and yellow (E). H-bonds are represented by black dashed lines.
doi:10.1371/journal.pone.0029346.g005
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29346Figure 6. CYP1A protein expression patterns are ligand- and AHR isoform-dependent. CYP1A expression at 120 hpf in (A) ahr2
+ and (B)
ahr2
hu3335 larvae following exposure to 1 nM TCDD from 6–24 hpf. C) Leflunomide-induced CYP1A expression at 72 hpf in wild-type and (D)
ahr2
hu3335 mutants. E) Leflunomide-induced CYP1A expression in AHR1B-morphant ahr2
hu3335 larvae and F) ahr2
hu3335 larvae co-injected with AHR1A
and AHR1B morpholinos. (G) DMSO control. TCDD-exposed embryos were IHC processed side-by-side and imaged at 120 hpf using the same
exposure settings and a single focal plane. Leflunomide-exposed embryos and DMSO control were processed side-by-side and imaged at 72 hpf
using the same exposure times; images were created from a z-stack of 10 15.4 uM slices centered on the liver.
doi:10.1371/journal.pone.0029346.g006
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endogenous and ligand-mediated roles of the AHR in developing
vertebrates.
Materials and Methods
Zebrafish lines and embryos
Adult zebrafish were housed according to Institutional Animal
Care and Use Committee protocols at Oregon State University on
a recirculating system with water temperature of 2861uC and a
14 h light/10 h dark schedule. Zebrafish embryos carrying a point
mutation in ahr2 (ahr2
hu3335 strain) were requested and generously
provided by the Hubrecht Institute. The ahr2
hu3335 line was
identified from a library of N-ethyl-N-nitrosourea (ENU)-muta-
genized zebrafish using the TILLING method as previously
described [51]. Offspring of heterozygous ahr2
hu3335 carriers were
raised to adulthood at the Sinnhuber Aquatic Research Labora-
tory, and genotyped for the ahr2
hu3335 point mutation with DNA
isolated from fin clips [51]. PCR amplification was performed with
genomic DNA and ahr2 gene-specific primers (Table 4), the
product was purified using a QIAquick PCR purification kit
(Qiagen) and sequenced with an ABI 3730 capillary sequencer at
the Center for Genome Research and Biocomputing at Oregon
State University. Homozygous carriers of the T to A point
mutation in residue 534 (Figure 1) were identified to create an
ahr2
hu3335 population. Because the TILLING method relies on
random mutagenesis, mutant lines of interest carry other
mutations throughout the genome. F1 fish are predicted to carry
3–6000 mutations and multiple outcrosses are necessary to reduce
off-target mutations [52]. ahr2
hu3335 carriers were outcrossed to the
wild type 5D (ahr2
+/+) line, and homozygous mutants were
identified from an incross of their progeny. The ahr2
hu3335 mutant
line has been maintained with subsequent outcrosses on the wild
type 5D background, which was also used for all ahr2
+ control
experiments in our laboratory.
All developmental toxicity experiments were conducted with
fertilized embryos obtained from group spawns of adult zebrafish
as described previously [53]. Embryos used in experiments are
defined as homozygous (ahr2
hu3335), heterozygous (ahr2
hu3335/+)o r
wild-type (ahr2
+) for the point mutation in AHR2.
MicroCt imaging
Micro computed tomography (mCT) was used for nondestruc-
tive three-dimensional imaging of zebrafish heads. The fish were
scanned using a Scanco mCT40 scanner (Scanco Medical AG,
Basserdorf, Switzerland) at 45 kVp, 177 mA, and a voxel size of
12612612 mm. The heads were imaged at threshold settings of
140 (scale 0–1000).
Homology modeling, molecular docking and binding
energy calculations
Molecular modeling of zebrafish AHR2, AHR1B and AHR1A
isoforms was conducted as described previously (17). Briefly, the
homology models of mouse, human, rat and zebrafish AHR-LBD
(ligand binding domains) were built using the NMR resolved
structure of the PAS domain of human hypoxia-inducible-factor
2a as the 3D-template. Models were then refined in the internal
Table 3. Summary of zebrafish AHR ligand binding, activity and expression.
Receptor
Receptor mRNA expression in adult
zebrafish
In vitro TCDD
binding and
activity
Homology model predicted
binding
Dominant receptor-dependent
CYP1A protein induction pattern
(larval)
TCDD Leflunomide
AHR1A heart, swimbladder, liver, kidney [21] N [21,23] N Y liver
AHR1B NA Y [23] Y Y vasculature
AHR2 brain, heart, muscle, swimbladder,
liver, gill, skin, eye, kidney, fin [21]
Y [21,23] Y Y liver, vasculature
doi:10.1371/journal.pone.0029346.t003
Table 4. Primer sequences for PCR experiments.
Target Forward Primer (59-3 9) Reverse Primer (59-3 9)
AHR1A CGCAAAAGGAGGAAACCTGTC [47] CCTGTAGCAAAAATTCCCCCT [47]
AHR1B GGTTTGTCGTCAAACAACAGTAACCACG [23] CCACCAACACAAAGCCATTAAGAGCCTG [23]
AHR1B-mo CTTTGTGTGTCGTTTCCGATGCC GCACAGTAGAGCATATCAGCTGC
AHR2 TGGACTAGATCAGACAACCC GAAGAGGGAGAGTCATTGTG
AHR2-mut TATTGCTAGGCAGAGAGCAC GATGTCTTCTGTGATGATTTCG
CYP1A TGCCGATTTCATCCCTTTCC AGAGCCGTGCTGATAGTGTC
CYP1B1 CTGCATTGATTTCCGAGACGTG [59] CACACTCCGTGTTGACAGC [59]
CYP1C1 AGTGGCACAGTCTACTTTGAGAG [59] TCGTCCATCAGCACTCAG [59]
CYP1C2 GTGGTGGAGCACAGACTAAG [59] TTCAGTATGAGCCTCAGTCAAAC [59]
b-ACTIN AAGCAGGAGTACGATGAGTC TGGAGTCCTCAGATGCATTG
mo- morpholino mis-splice detection.
mut- mutant point mutation detection.
doi:10.1371/journal.pone.0029346.t004
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TCDD and leflunomide ligands and binding energy calculation
were performed as reported [17].
Chemical exposures and developmental toxicity
assessment
TCDD (99.2% purity in DMSO, Cambridge Isotope Labora-
tories) and leflunomide (Sigma-Aldrich) were dissolved in DMSO.
All exposures were conducted in E2 embryo medium with staged
embryos [54]. Embryos were batch exposed to 0.1, 1, 10 nM
TCDD or 0.1% DMSO vehicle control in 2 mL embryo medium
in glass vials from 6–24 hours post fertilization (hpf). Embryos
were then rinsed 46with embryo media and transferred to plastic
dishes to develop until the indicated experimental time points.
Embryo homogenate for mRNA expression analysis was collected
at 48 hpf, and developmental toxicity of TCDD exposure was
assessed by visually inspecting embryos at 120 hpf for malforma-
tions as previously described [55] with three biological replicates.
Developmental toxicity assay data were analyzed by fitting a 2
parameter logistic regression model to the concentration-response
data for each malformation. Significance of the TCDD concen-
tration-response curve was calculated for each fish line. Differen-
tial responses were assessed with a t-test to compare the
parameters from the ahr2
+ model to those from the ahr2
hu3335
model. No adjustment for multiplicity was made. R software v12.0
[56] was used for these analyses.
For leflunomide exposures, embryos were transferred into
individual wells of a 96-well plate and exposed to 10 mM
leflunomide or 0.1% DMSO control in 100 ml embryo medium
from 48–72 hpf, when they were humanely euthanized and fixed
for immunohistochemistry analysis.
Total RNA isolation and reverse transcription
For qRT-PCR studies, 20 embryos per treatment group were
homogenized in TRIzol (Invitrogen) and stored at 280uC until
use. Total RNA was isolated via phenol/guanidine isothiocya-
nate/chloroform separation. For morpholino splice-blocking
confirmation, 15 embryos were homogenized in RNAzol (Molec-
ular Research Center) for total RNA isolation. RNA was
quantified using a SynergyMx microplate reader (Biotek) with
the Gen5 Take3 module to calculate 260/280 O.D. ratios.
Superscript III First-Strand Synthesis (Invitrogen) was used with
oligo(dT) primer to reverse transcribe cDNA from total RNA.
Quantitative RT-PCR
Relative abundance of AHR1A, AHR1B, AHR2, CYP1A,
CYP1B1, CYP1C1 and CYP1C2 mRNA transcripts were assessed
in whole embryo homogenate. Gene-specific primers (MWG
Operon) are listed in Table 4. All qRT-PCR assays were performed
in 20 ml reactions consisting of 10 ml Power SYBR Green PCR
master mix (Applied Biosystems), 0.4 ul each primer, 9.2 ul H2O
and 50 ng equivalents of cDNA. Amplification (Step One Plus,
Applied Biosystems) was performed with cycling parameters as
follows: 95uC for 10 min; 40 cycles of 95uC for 15 s, 60uC for
1 min; 95uC for 15 sec and 60uC for 1 min. A melt curve was
performed at 3u increments to assess for multiple products.
qRT-PCR analysis was performed with StepOne Software v2.1
(Applied Biosystems) using the DDCt method with genes of interest
normalized to b-actin [57]. Three independent biological
replicates were assessed and statistically analyzed by comparing
ahr2
hu3335 to ahr2
+ or TCDD-treated to control with a Student’s t-
test using Graphpad Prism 5.01 software (Graphpad Software Inc.
La Jolla, CA).
Morpholino injection
Splice-blocking morpholinos designed against AHR1A and
AHR1B were purchased from Gene Tools (Philomath, OR). The
AHR1A splice-blocking morpholino (AHR1Amo, 59 CTTTT
GAAGTGACTTTTGGCCCGCA 39) was described previously
[47] and was tagged on the 39 end with fluorescein. We designed a
morpholino to target the exon7/intron7 boundary of AHR1B
(AHR1Bmo, 59 ACACAGTCGTCCATGATTACTTTGC 39). A
standard control morpholino from Gene Tools (cmo, 59
CCTCTTACCTCAGTTACAATTTATA 39) was used as a
negative control. ahr2
hu3335 embryos were injected at the 1–2 cell
stage with approximately 2 nl of 1.5 mM morpholino dissolved
in ultrapure water with 0.5% phenol red. For AHR1Amo
+AHR1Bmo co-injections, the final concentration of each
morpholino was 0.83 mM. Embryos were allowed to develop in
fish water and screened for successful morpholino incorporation
with fluorescein visualization at 24 hpf. mRNA mis-splice was
confirmed with PCR primers flanking the target sites at 24 and 72
hpf (AHR1A and AHR1B-mo primers Table 4).
Immunohistochemistry (IHC)
Wild-type strain 5D and ahr2
hu3335 embryos treated with 1 nM
TCDD (or 0.1% DMSO control) from 6–24 hpf were fixed at 120
hpf in 4% paraformaldehyde (J.T. Baker) overnight at 4uC.
Leflunomide treated embryos (48–72 hpf) were fixed at 72 hpf to
capture the window of morpholino efficacy. Mouse a fish CYP1A
monoclonal (1:500 dilution, Biosense laboratories) and goat a
human HNF4a polyclonal (1:100 dilution, Santa Cruz Biotech-
nology) primary antibodies were used. Secondary antibodies
consisted of AlexafluorH 546 rabbit a mouse IgG (H+L) (1:1000)
and AlexafluorH 488 donkey a goat IgG (H+L) (1:1000)
(Molecular Probes, Eugene, OR). Immunohistochemistry was
performed as previously described [27]. Briefly, whole fixed
embryos were permeabilized with 0.005% trypsin on ice for
10 min, washed 36with PBST and post-fixed in 4% paraformal-
dehyde for 10 min. Samples were blocked for 1 h in 10% normal
goat serum (single labeling) or BlockAid (double labeling)
(Invitrogen). Samples were incubated with primary antibodies
overnight at 4uC, followed by 4 30 min washes in PBST and
incubation with secondary antibody overnight at 4uC. At least 8
embryos per treatment group were imaged by epi-fluorescence
microscopy using a Zeiss Axiovert 200 M microscope with 56and
106objectives.
Supporting Information
Figure S1 Confirmation of morpholino target mis-
splice. PCR amplification of AHR1A and AHR1B fragments
spanning the morpholino target sites were performed with mRNA
isolated from 72 hpf whole embryo homogenate. Lane 1: control
morpholino (cmo) injected, Lane 2: AHR1A+AHR1Bmo injected,
Lane 3: AHR1Bmo injected. WT: wild-type, INS: insertion, DEL:
deletion.
(TIF)
Acknowledgments
We gratefully acknowledge Edwin Cuppen at the Hubrecht Institute for
the ahr2
hu3335 line and the European Commission Consortium Integrated
Project ‘‘ZF-MODELS-Zebrafish Models for Human Development and
Disease’’, Contract No. LSHG-CT-2003-503496. We would like to thank
the Skeletal Biology Laboratory at OSU for the microCt analysis, and the
Center for Genome Research and Biocomputing at OSU for sequencing
support. We are grateful to Cari Buchner, Carrie Barton, Brittany
McCauslin, Jessika Dobson and the staff at the Sinnhuber Aquatic
Functional Diversity of Zebrafish AHRs
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e29346Research Laboratory for fish husbandry expertise and to members of the
Tanguay laboratory for their helpful feedback and critical review of the
manuscript.
Author Contributions
Conceived and designed the experiments: BCG RLT. Performed the
experiments: BCG JKL WHB. Analyzed the data: BCG WHB DBJ KMW.
Contributed reagents/materials/analysis tools: KMW RLT. Wrote the
manuscript: BCG RLT.
References
1. Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O (1995) Identification
of functional domains of the aryl hydrocarbon receptor. J Biol Chem 270:
29270–29278.
2. Fukunaga BN, Hankinson O (1996) Identification of a novel domain in the aryl
hydrocarbon receptor required for DNA binding. J Biol Chem 271: 3743–3749.
3. Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by
structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol
Toxicol 43: 309–334.
4. Nebert DW, Robinson JR, Niwa A, Kumaki K, Poland AP (1975) Genetic
expression of aryl hydrocarbon hydroxylase activity in the mouse. J Cell Physiol
85: 393–414.
5. Schmidt JV, Bradfield CA (1996) Ah receptor signaling pathways. Annu Rev
Cell Dev Biol 12: 55–89.
6. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, et al. (2000) Role of the
aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress
response, cell cycle control, and apoptosis. Biochem Pharmacol 59: 65–85.
7. Sartor MA, Schnekenburger M, Marlowe JL, Reichard JF, Wang Y, et al. (2009)
Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an
extensive array of gene clusters that control morphogenetic and developmental
programs. Environ Health Perspect 117: 1139–1146.
8. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon
receptor-mediated induction of the CYP1 enzymes in environmental toxicity
and cancer. J Biol Chem 279: 23847–23850.
9. Gu YZ, Hogenesch JB, Bradfield CA (2000) The PAS superfamily: sensors of
environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:
519–561.
10. Kerkvliet NI (2009) AHR-mediated immunomodulation: the role of altered gene
transcription. Biochem Pharmacol 77: 746–760.
11. Puga A, Ma C, Marlowe JL (2009) The aryl hydrocarbon receptor cross-talks
with multiple signal transduction pathways. Biochem Pharmacol 77: 713–722.
12. Hahn ME (2002) Aryl hydrocarbon receptors: diversity and evolution. Chem
Biol Interact 141: 131–160.
13. Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, et al. (1994) Dioxin binding
activities of polymorphic forms of mouse and human arylhydrocarbon receptors.
J Biol Chem 269: 27337–27343.
14. Wirgin I, Roy NK, Loftus M, Chambers RC, Franks DG, et al. Mechanistic
basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science
331: 1322–1325.
15. Hahn ME, Karchner SI, Evans BR, Franks DG, Merson RR, et al. (2006)
Unexpected diversity of aryl hydrocarbon receptors in non-mammalian
vertebrates: insights from comparative genomics. J Exp Zool A Comp Exp Biol
305: 693–706.
16. Murray IA, Flaveny CA, Chiaro CR, Sharma AK, Tanos RS, et al. (2011)
Suppression of cytokine-mediated complement factor gene expression through
selective activation of the Ah receptor with 39,49-dimethoxy-alpha-naphtho-
flavone. Mol Pharmacol 79: 508–519.
17. Bisson WH, Koch DC, O’Donnell EF, Khalil SM, Kerkvliet NI, et al. (2009)
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its
utility in virtual ligand screening to predict new AhR ligands. J Med Chem 52:
5635–5641.
18. Billiard SM, Hahn ME, Franks DG, Peterson RE, Bols NC, et al. (2002) Binding
of polycyclic aromatic hydrocarbons (PAHs) to teleost aryl hydrocarbon
receptors (AHRs). Comp Biochem Physiol B Biochem Mol Biol 133: 55–68.
19. Carney SA, Prasch AL, Heideman W, Peterson RE (2006) Understanding
dioxin developmental toxicity using the zebrafish model. Birth Defects Res A Clin
Mol Teratol 76: 7–18.
20. Postlethwait J, Amores A, Cresko W, Singer A, Yan YL (2004) Subfunction
partitioning, the teleost radiation and the annotation of the human genome.
Trends Genet 20: 481–490.
21. Andreasen EA, Hahn ME, Heideman W, Peterson RE, Tanguay RL (2002) The
zebrafish (Danio rerio) aryl hydrocarbon receptor type 1 is a novel vertebrate
receptor. Mol Pharmacol 62: 234–249.
22. Tanguay RL, Abnet CC, Heideman W, Peterson RE (1999) Cloning and
characterization of the zebrafish (Danio rerio) aryl hydrocarbon receptor.
Biochim Biophys Acta 1444: 35–48.
23. Karchner SI, Franks DG, Hahn ME (2005) AHR1B, a new functional aryl
hydrocarbon receptor in zebrafish: tandem arrangement of ahr1b and ahr2
genes. Biochem J 392: 153–161.
24. Antkiewicz DS, Peterson RE, Heideman W (2006) Blocking expression of AHR2
and ARNT1 in zebrafish larvae protects against cardiac toxicity of 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Toxicol Sci 94: 175–182.
25. Prasch AL, Teraoka H, Carney SA, Dong W, Hiraga T, et al. (2003) Aryl
hydrocarbon receptor 2 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin develop-
mental toxicity in zebrafish. Toxicol Sci 76: 138–150.
26. Teraoka H, Dong W, Tsujimoto Y, Iwasa H, Endoh D, et al. (2003) Induction of
cytochrome P450 1A is required for circulation failure and edema by 2,3,7,8-
tetrachlorodibenzo-p-dioxin in zebrafish. Biochem Biophys Res Commun 304:
223–228.
27. Mathew LK, Andreasen EA, Tanguay RL (2006) Aryl hydrocarbon receptor
activation inhibits regenerative growth. Mol Pharmacol 69: 257–265.
28. Billiard SM, Timme-Laragy AR, Wassenberg DM, Cockman C, Di Giulio RT
(2006) The role of the aryl hydrocarbon receptor pathway in mediating
synergistic developmental toxicity of polycyclic aromatic hydrocarbons to
zebrafish. Toxicol Sci 92: 526–536.
29. Hernandez-Ochoa I, Karman BN, Flaws JA (2009) The role of the aryl
hydrocarbon receptor in the female reproductive system. Biochem Pharmacol
77: 547–559.
30. Singh KP, Casado FL, Opanashuk LA, Gasiewicz TA (2009) The aryl
hydrocarbon receptor has a normal function in the regulation of hematopoietic
and other stem/progenitor cell populations. Biochem Pharmacol 77: 577–587.
31. Matsumura F, Puga A, Tohyama C (2009) Biological functions of the
arylhydrocarbon receptor: beyond induction of cytochrome P450s. Introduction
to this special issue. Biochem Pharmacol 77: 473.
32. Peterson RE, Theobald HM, Kimmel GL (1993) Developmental and
reproductive toxicity of dioxins and related compounds: cross-species compar-
isons. Crit Rev Toxicol 23: 283–335.
33. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA (1996)
Characterization of a murine Ahr null allele: involvement of the Ah receptor
in hepatic growth and development. Proc Natl Acad Sci U S A 93: 6731–6736.
34. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, et al. (1995)
Immune system impairment and hepatic fibrosis in mice lacking the dioxin-
binding Ah receptor. Science 268: 722–726.
35. Lahvis GP, Pyzalski RW, Glover E, Pitot HC, McElwee MK, et al. (2005) The
aryl hydrocarbon receptor is required for developmental closure of the ductus
venosus in the neonatal mouse. Mol Pharmacol 67: 714–720.
36. Wittkopp N, Huntzinger E, Weiler C, Sauliere J, Schmidt S, et al. (2009)
Nonsense-mediated mRNA decay effectors are essential for zebrafish embryonic
development and survival. Mol Cell Biol 29: 3517–3528.
37. Cubbage CC, Mabee PM (1996) Development of the cranium and paired fins in
the zebrafish Danio rerio (Ostariophysi, cyprinidae). Journal of Morphology 229:
121–160.
38. Jonsson ME, Jenny MJ, Woodin BR, Hahn ME, Stegeman JJ (2007) Role of
AHR2 in the expression of novel cytochrome P450 1 family genes, cell cycle
genes, and morphological defects in developing zebra fish exposed to 3,39,4,49,5-
pentachlorobiphenyl or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 100:
180–193.
39. O’Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, et al. (2010) The
anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon
receptor. PLoS One 5.
40. Pandini A, Denison MS, Song Y, Soshilov AA, Bonati L (2007) Structural and
functional characterization of the aryl hydrocarbon receptor ligand binding
domain by homology modeling and mutational analysis. Biochemistry 46:
696–708.
41. Pandini A, Soshilov AA, Song Y, Zhao J, Bonati L, et al. (2009) Detection of the
TCDD binding-fingerprint within the Ah receptor ligand binding domain by
structurally driven mutagenesis and functional analysis. Biochemistry 48:
5972–5983.
42. Andreasen EA, Spitsbergen JM, Tanguay RL, Stegeman JJ, Heideman W, et al.
(2002) Tissue-specific expression of AHR2, ARNT2, and CYP1A in zebrafish
embryos and larvae: effects of developmental stage and 2,3,7,8-tetrachlorodi-
benzo-p-dioxin exposure. Toxicol Sci 68: 403–419.
43. Carney SA, Peterson RE, Heideman W (2004) 2,3,7,8-Tetrachlorodibenzo-p-
dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor
nuclear translocator pathway causes developmental toxicity through a CYP1A-
independent mechanism in zebrafish. Mol Pharmacol 66: 512–521.
44. Dong PD, Munson CA, Norton W, Crosnier C, Pan X, et al. (2007) Fgf10
regulates hepatopancreatic ductal system patterning and differentiation. Nat
Genet 39: 397–402.
45. Abbott BD, Schmid JE, Pitt JA, Buckalew AR, Wood CR, et al. (1999) Adverse
reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol
Appl Pharmacol 155: 62–70.
46. Incardona JP, Carls MG, Teraoka H, Sloan CA, Collier TK, et al. (2005) Aryl
hydrocarbon receptor-independent toxicity of weathered crude oil during fish
development. Environ Health Perspect 113: 1755–1762.
47. Incardona JP, Day HL, Collier TK, Scholz NL (2006) Developmental toxicity of
4-ring polycyclic aromatic hydrocarbons in zebrafish is differentially dependent
on AH receptor isoforms and hepatic cytochrome P4501A metabolism. Toxicol
Appl Pharmacol 217: 308–321.
Functional Diversity of Zebrafish AHRs
PLoS ONE | www.plosone.org 12 January 2012 | Volume 7 | Issue 1 | e2934648. Incardona JP, Linbo TL, Scholz NL. Cardiac toxicity of 5-ring polycyclic
aromatic hydrocarbons is differentially dependent on the aryl hydrocarbon
receptor 2 isoform during zebrafish development. Toxicol Appl Pharmacol.
49. Scott JA, Incardona JP, Pelkki K, Shepardson S, Hodson PV (2011) AhR2-
mediated, CYP1A-independent cardiovascular toxicity in zebrafish (Danio rerio)
embryos exposed to retene. Aquat Toxicol 101: 165–174.
50. Gonzalez FJ, Fernandez-Salguero P (1998) The aryl hydrocarbon receptor:
studies using the AHR-null mice. Drug Metab Dispos 26: 1194–1198.
51. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RH, et al. (2003)
Efficient target-selected mutagenesis in zebrafish. Genome Res 13: 2700–2707.
52. Moens CB, Donn TM, Wolf-Saxon ER, Ma TP (2008) Reverse genetics in
zebrafish by TILLING. Brief Funct Genomic Proteomic 7: 454–459.
53. Reimers MJ, La Du JK, Periera CB, Giovanini J, Tanguay RL (2006) Ethanol-
dependent toxicity in zebrafish is partially attenuated by antioxidants.
Neurotoxicol Teratol 28: 497–508.
54. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages
of embryonic development of the zebrafish. Dev Dyn 203: 253–310.
55. Truong L, Harper SL, Tanguay RL (2011) Evaluation of embryotoxicity using
the zebrafish model. Methods Mol Biol 691: 271–279.
56. (2010) R: A language and environment for statistical computing. In: Team
RDC, editor. Vienna, Austria.
57. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
58. Hahn ME (1998) The aryl hydrocarbon receptor: a comparative perspective.
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 121: 23–53.
59. Jonsson ME, Franks DG, Woodin BR, Jenny MJ, Garrick RA, et al. (2009) The
tryptophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) binds multiple
AHRs and induces multiple CYP1 genes via AHR2 in zebrafish. Chem Biol
Interact.
Functional Diversity of Zebrafish AHRs
PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e29346